Patients with schizophrenia showed significantly lower ADAR2 expressions in both Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)- and CFL1-normalized data (P < 0.05). This evidence concerns the gene CFL1 and schizophrenia.